LLY

1,100.06

+3.42%↑

JNJ

206.93

+1.09%↑

ABBV

232.11

-0.3%↓

UNH

325.14

+1.02%↑

AZN

93.17

+1.75%↑

LLY

1,100.06

+3.42%↑

JNJ

206.93

+1.09%↑

ABBV

232.11

-0.3%↓

UNH

325.14

+1.02%↑

AZN

93.17

+1.75%↑

LLY

1,100.06

+3.42%↑

JNJ

206.93

+1.09%↑

ABBV

232.11

-0.3%↓

UNH

325.14

+1.02%↑

AZN

93.17

+1.75%↑

LLY

1,100.06

+3.42%↑

JNJ

206.93

+1.09%↑

ABBV

232.11

-0.3%↓

UNH

325.14

+1.02%↑

AZN

93.17

+1.75%↑

LLY

1,100.06

+3.42%↑

JNJ

206.93

+1.09%↑

ABBV

232.11

-0.3%↓

UNH

325.14

+1.02%↑

AZN

93.17

+1.75%↑

Search

West Pharmaceutical Services Inc

Aperta

SettoreSettore sanitario

280.2 2.5

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

271.95

Massimo

280.84

Metriche Chiave

By Trading Economics

Entrata

8.2M

140M

Vendite

38M

804M

P/E

Media del settore

38.933

106.172

EPS

1.96

Rendimento da dividendi

0.32

Margine di Profitto

17.406

Dipendenti

10,600

EBITDA

19M

217M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+27.58% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.32%

2.31%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-889M

19B

Apertura precedente

277.7

Chiusura precedente

280.2

Notizie sul Sentiment di mercato

By Acuity

50%

50%

181 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 nov 2025, 21:54 UTC

Acquisizioni, Fusioni, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24 nov 2025, 18:26 UTC

I principali Market Mover

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24 nov 2025, 23:49 UTC

Discorsi di Mercato

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24 nov 2025, 23:08 UTC

Discorsi di Mercato

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24 nov 2025, 23:08 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

24 nov 2025, 22:56 UTC

Discorsi di Mercato
Utili

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24 nov 2025, 22:47 UTC

Discorsi di Mercato

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24 nov 2025, 22:36 UTC

Discorsi di Mercato
Utili

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24 nov 2025, 22:32 UTC

Utili

Webco Industries 1Q EPS $6.79 >WEBC

24 nov 2025, 22:07 UTC

Utili

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24 nov 2025, 22:07 UTC

Utili

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24 nov 2025, 22:06 UTC

Utili

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 nov 2025, 22:06 UTC

Utili

Couche-Tard 2Q Rev $17.9B >ATD.T

24 nov 2025, 22:06 UTC

Utili

Couche-Tard 2Q EPS 79c >ATD.T

24 nov 2025, 22:05 UTC

Utili

Couche-Tard 2Q Rev $17.9B >ATD.T

24 nov 2025, 22:05 UTC

Utili

Couche-Tard 2Q Net $740.6M >ATD.T

24 nov 2025, 22:05 UTC

Utili

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 nov 2025, 22:05 UTC

Utili

Couche-Tard 2Q EPS 79c >ATD.T

24 nov 2025, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

24 nov 2025, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

24 nov 2025, 21:44 UTC

Discorsi di Mercato

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24 nov 2025, 21:39 UTC

Acquisizioni, Fusioni, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24 nov 2025, 20:42 UTC

Discorsi di Mercato

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24 nov 2025, 20:41 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Settle Lower -- Market Talk

24 nov 2025, 19:56 UTC

Acquisizioni, Fusioni, Takeovers

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24 nov 2025, 18:26 UTC

Discorsi di Mercato

Crude Futures Move Higher in Choppy Trade -- Market Talk

24 nov 2025, 17:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

24 nov 2025, 17:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

24 nov 2025, 17:09 UTC

Discorsi di Mercato

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24 nov 2025, 16:52 UTC

Acquisizioni, Fusioni, Takeovers

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

27.58% in crescita

Previsioni per 12 mesi

Media 349.56 USD  27.58%

Alto 375 USD

Basso 311 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

11 ratings

10

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

181 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat